<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=412980&amp;fmt=gif">
LSX World Congress USA

 

7 -8 October 2019 | Convene Convention Center | Boston | USA

2018 speakers

The LSX World Congress USA is a CxO level conference and attracts high-quality speakers from investors, biotechs and pharma creating an agenda to educate investors and corporates on the most exciting new technology and therapeutic areas in healthcare today. 

Previous speakers have included:

Ivana Magovčević-Liebisch, EVP & Chief Business Officer, Ipsen

Ivana Magovčević-Liebisch

EVP & Chief Business Officer
Ipsen
Noubar Afeyan, Founder and CEO, Flagship Pioneering

Noubar Afeyan

Founder and CEO
Flagship Pioneering
Boris Zaitra, Global Head of M&A, Roche

Boris Zaitra

Global Head of M&A
Roche
Neil Exter, Partner, Third Rock Ventures

Neil Exter

Partner
Third Rock Ventures
James Kasuboski, Director, Boehringer

James Kasuboski

Director
Boehringer Ingelheim Venture Fund USA
Michal Silverberg, Managing Director, Novartis Venture Fund

Michal Silverberg

Managing Director
Novartis Venture Fund
Todd Foley, Managing Director, MPM Capital

Todd Foley

Managing Director
MPM Capital
Alexandra Glucksmann, CEO, Cedilla Therapeutics

Alexandra Glucksmann

CEO
Cedilla Therapeutics
Rob Brainin, CEO, WuXi NextCODE

Rob Brainin

CEO
WuXi NextCODE
Michael Sherman, SVP and Chief Medical Officer, Harvard Pilgrim Health Care

Michael Sherman

SVP and Chief Medical Officer
Harvard Pilgrim Health Care
Alex de Winter, Managing Director, GE Ventures

Alex de Winter

Managing Director
GE Ventures
Paul Biondi, SVP Head of BD, Bristol-Myers Squibb

Paul Biondi

SVP, Strategy and Business Development
Bristol-Myers Squibb
Russ Johannesson, CEO, Glooko

Russ Johannesson

CEO
Glooko
Nigel Sheail, Global Head of M&A and BD&L, Novartis

Nigel Sheail

Global Head of M&A and BD&L
Novartis
Ed Addison, Chairman and CEO,  Cloud Pharmaceuticals

Ed Addison

CEO
Cloud Pharmaceuticals
Sohang Chatterjee, CEO, EnBiome Therapeutics

Sohang Chatterjee

CEO
EnBiome Therapeutics
Dennis Grishin, Co-Founder, Nebula Genomics

Dennis Grishin

Co-Founder
Nebula Genomics
Philip Strandwitz, CEO, HoloBiome

Philip Strandwitz

CEO
HoloBiome
Andrew Elbardissi, Principal, Deerfield

Andrew Elbardissi

Principal
Deerfield
Niven Narain, CEO, Berg Health

Niven Narain

CEO
Berg Health
David Donabedian, CEO, AXIAL Biotherapeutics

David Donabedian

CEO
AXIAL Biotherapeutics
Douglas Russell, SVP, LaVoieHealthSciences

Douglas Russell

SVP
LaVoieHealthSciences
Josh Mandel-Brehm, CEO, CAMP4 Therapeutics

Josh Mandel-Brehm

CEO
CAMP4 Therapeutics
Paul Wotton

Paul Wotton

CEO
Sigilon Therapeutics
Adam Kaufman, CEO, Canary Health

Adam Kaufman

CEO
Canary Health
Jay Goth, Managing Partner, Forentis Fund

Jay Goth

Managing Partner
Forentis Fund
Leila Pirhaji, Founder and CEO, ReviveMed

Leila Pirhaji

Founder and CEO
ReviveMed
Todd Krueger, CEO, AOBiome Therapeutics

Todd Krueger

CEO
AOBiome Therapeutics
Brian Rye, Senior Health-Care Policy Analyst, Government Team, Bloomberg Intelligence

Brian Rye

Senior Health-Care Policy Analyst, Government Team
Bloomberg Intelligence
Jason Hafler, Senior Director of Investments, Sanofi Ventures

Jason Hafler

Senior Director of Investments
Sanofi Ventures
Alicia Irurzun-Lafitte, Principal, MS-Ventures

Alicia Irurzun-Lafitte

Principal
MS-Ventures
Mark Smith, CEO, Finch Therapeutics

Mark Smith

CEO
Finch Therapeutics
Scott Shandler, CEO, Longevity Biotech

Scott Shandler

CEO
Longevity Biotech
George Church, Professor of Genetics, Harvard Medical School

George Church

Professor of Genetics
Harvard Medical School
Joris Van Dam, Head Digital Therapeutics, Novartis

Joris Van Dam

Head Digital Therapeutics
Novartis
Chrissa McFarlane, CEO, Patientory

Chrissa McFarlane

CEO
Patientory
Eddie Martucci, CEO, Akili Interactive

Eddie Martucci

CEO
Akili Interactive
Joseph Cawley, CSO, Encrypgen

Joseph Cawley

CSO
Encrypgen
Gini Deshpande, Founder & CEO, NuMedii

Gini Deshpande

Founder & CEO
NuMedii
Sandy Li, Vice President, Baidu Ventures

Sandy Li

Vice President
Baidu Ventures
Geoff Mackay, CEO, AvroBio

Geoff Mackay

CEO
AvroBio
Jai Balkissoon, VP Immuno-Oncology, Global Product Development, PPD

Jai Balkissoon

VP Immuno-Oncology, Global Product Development
PPD
Neil Mahapatra, Chairman, Oxford Cannabinoid Technologies

Neil Mahapatra

Chairman
Oxford Cannabinoid Technologies
Lewis Geffen, Co-Chair, Life Science and VC & Emerging Companies Practice, Mintz Levin

Lewis Geffen

Co-Chair, Life Science and VC & Emerging Companies Practice
Mintz Levin
Daniel O’Connell, CEO, Acumen Pharma

Daniel O’Connell

CEO
Acumen Pharma
Dean Petkanas, CEO, Kannalife Sciences

Dean Petkanas

CEO
Kannalife Sciences
Aradhana Sarin, SVP, Head of BD & Strategy, Alexion Pharmaceuticals

Aradhana Sarin

SVP, Head of BD & Strategy
Alexion Pharmaceuticals
Marshall Smith, Global Head of Healthcare, Goldman Sachs

Marshall Smith

Global Head of Healthcare
Goldman Sachs
Drew Volpe, Founding Partner, First Star Ventures

Drew Volpe

Founding Partner
First Star Ventures
Karan Wadhera, Managing Partner, Casa Verde Capital

Karan Wadhera

Managing Partner
Casa Verde Capital
Greg Gorgas, CEO, Artelo Biosciences

Greg Gorgas

CEO
Artelo Biosciences
Brian Pereira, CEO, Visterra

Brian Pereira

CEO
Visterra
David Benshoof Klein, CEO,

David Benshoof Klein

CEO
Click Therapeutics
Doug Giordano, VP Business Development, Pfizer

Doug Giordano

VP Business Development
Pfizer
Aaron Kantoff, Principal, Apple Tree Partners

Aaron Kantoff

Principal
Apple Tree Partners
Janna Hutz, Senior Director, Head of Human Biology & Data Science, Eisai

Janna Hutz

Senior Director, Head of Human Biology & Data Science
Eisai
Giovanni Mariggi, Partner, MEdixci

Giovanni Mariggi

Partner
MEdixci
Thomas Hughes, CEO, Navitor Pharmaceuticals

Thomas Hughes

CEO
Navitor Pharmaceuticals
Jim Broderick, CEO, Palleon Pharmaceuticals

Jim Broderick

CEO
Palleon Pharmaceuticals
Paulina Hill, Principal, Polaris Partners

Paulina Hill

Principal
Polaris Partners
Brett Zbar, Managing Director, Foresite Capital Management

Brett Zbar

Managing Director
Foresite Capital Management
Philip Astley-Sparke, Venture Partner, Forbion Capital Partners

Philip Astley-Sparke

Venture Partner
Forbion Capital Partners
Mark Chin, Investment Director, Arix Bioscience

Mark Chin

Investment Director
Arix Bioscience
Rosemary G Reilly, Partner, WilmerHale

Rosemary G. Reilly

Partner
WilmerHale
Philip Lee, COO and Co-Founder, Senti Biosciences

Philip Lee

COO and Co-Founder
Senti Biosciences
Michael Margolis, Co-Head of Healthcare Investment Banking, Oppenheimer

Michael Margolis

Co-Head of Healthcare Investment Banking
Oppenheimer
Mike Fitzgerald, Managing Director, Nasdaq

Mike Fitzgerald

Managing Director
Nasdaq
Robert Ward, CEO, Eloxx Pharma

Robert Ward

Chairman and Chief Executive Officer
Eloxx Pharma
Kimberly Ha

Kimberly Ha

CEO & Founder
KKH Advisors
Chandra Ramanathan, VP & Head, East Cost Innovation Centre, Bayer

Chandra Ramanathan

VP & Head
East Cost Innovation Centre, Bayer
Marianne Hamilton Lopez

Marianne Hamilton Lopez

Research Director of Value-Based Payment Reform
Duke-Margolis
Arjun Goyal, Co-Founder and Managing Director, VIDA Ventures

Arjun Goyal, VIDA Ventures

Co-Founder and Managing Director
VIDA Ventures
Jordan Saxe, Senior Managing Director, Americas, Nasdaq-1

Jordan Saxe

Senior Managing Director, Americas
Nasdaq
Donna L. LaVoie, President & CEO, LaVoieHealthScience (1)

Donna LaVoie

President & CEO
LaVoieHealthScience
Paul Sagan, Investor and Corporate Comms, LavoieHealthSciences

Paul Sagan

AVP, Investor Relations and Corporate Communications
LaVoieHealthScience
The full agenda including up-to-date confirmed speakers, session content, timings and further information on the 1-2-1 partnering and networking and, satellite sessions is available on the brochure.
DOWNLOAD THE 2018 BROCHURE